State Street Corp Legend Biotech Corp Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Legend Biotech Corp stock. As of the latest transaction made, State Street Corp holds 1,135,487 shares of LEGN stock, worth $56.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,135,487
Previous 1,048,002
8.35%
Holding current value
$56.7 Million
Previous $58.8 Million
14.45%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding LEGN
# of Institutions
198Shares Held
74.2MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$573 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$375 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$331 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$286 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$238 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $8.36B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...